Follow
Oncology Molecular Diagnostic
Clinical Oncology evaluations can include various molecular tests and the results can influence patient care. One example of an Oncology Molecular Diagnostic is mutation analysis for genes known to be confer a high risk of cancer such as BRCA1/2. Healthy patients found to carry this mutation benefit from increased screening and surveillance due to their increased risk of several cancers.
What's Popular in Oncology Molecular Diagnostic
-
FEB 22, 2024Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char ...Written By: Carmen LeitchJAN 04, 2024Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca ...Written By: Carmen LeitchDEC 13, 2023Genetics & Genomics
Human immunity is an incredibly complex system that have to be very carefully regulated by the body. We need our immune ...Written By: Carmen LeitchNOV 10, 2023Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea ...Written By: Carmen LeitchOCT 24, 2023Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol ...Written By: Ryan Vingum
FEB 22, 2024
Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char
...
Written By:
Carmen Leitch
JAN 04, 2024
Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca
...
Written By:
Carmen Leitch
DEC 13, 2023
Genetics & Genomics
Human immunity is an incredibly complex system that have to be very carefully regulated by the body. We need our immune
...
Written By:
Carmen Leitch
NOV 10, 2023
Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea
...
Written By:
Carmen Leitch
OCT 24, 2023
Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol
...
Written By:
Ryan Vingum
OCT 11, 2023
Clinical & Molecular DX
Tumors in the central nervous system are particularly deadly. During surgery to remove a brain tumor, surgeons usually h
...
Written By:
Carmen Leitch
SEP 29, 2023
Clinical & Molecular DX
The brain is a crucial, sensitive organ that is well-protected by the skull and blood brain barrier, which prevents many
...
Written By:
Carmen Leitch
AUG 17, 2023
Technology
A recent study published in Nature Machine Intelligence examines a novel deep-learning method known as BigMHC, which can
...
Written By:
Laurence Tognetti, MSc
JUN 27, 2023
Clinical & Molecular DX
Tuberculosis is still a major health problem in much of the world. It was the primary cause of death from an infectious
...
Written By:
Carmen Leitch
-
NOV 30, 2023 | 12:00 PMC.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 08, 2023 | 8:00 AM
SiO2 Materials Science is a company with deep roots in materials science and engineering and a track record of innovative packaging products for pharmaceutical drugs. The company also manufa...
OCT 30, 2023 | 8:00 PM
Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 08, 2023 | 8:00 AM
SiO2 Materials Science is a company with deep roots in materials science and engineering and a track record of innovative packaging products for pharmaceutical drugs. The company also manufa...
OCT 30, 2023 | 8:00 PM
Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
OCT 26, 2023 | 8:00 AM
Description: Join this two-part webinar to learn when capillary electrophoresis is an ideal choice relative to other various sequencing technologies – such as next generation sequencin...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
Speaker:
Dr. Lucia Anna Muscarella, Ph.D.
, Dr. Cristina Guillén, Ph.D.
Sponsored By: Thermo Fisher Scientific
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
-
OCT 27, 2025C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......C.E. CREDITS
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...OCT 22, 2024 | 10:00 AM PDT
For the Love of Digital PCR 2024 virtual event Welcome to For the Love of Digital PCR 2024 – an immersive multi-day virtual event dedicated to exploring the remarkable capabilities of...JUN 12, 2024 | 1:00 PM PDTC.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...SEP 13, 2023 | 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
OCT 27, 2025
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
C.E. CREDITS
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...
OCT 22, 2024
| 10:00 AM PDT
For the Love of Digital PCR 2024 virtual event Welcome to For the Love of Digital PCR 2024 – an immersive multi-day virtual event dedicated to exploring the remarkable capabilities of...
JUN 12, 2024
| 1:00 PM PDT
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
SEP 13, 2023
| 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
NOV 09, 2022
| 5:30 AM PST
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....